Radioionidation reactions for radio pharmaceuticals: Compendium for effective synthesis strategies

Radioionidation Reactions for Pharmaceuticals: Compendium for Effective Synthesis Strategies

Volumn , Issue , 2006, Pages 1-101

  Coenen, Heinz H ^a   Mertens, John ^b   Mazieère, Bernard ^c   Bläuenstein, Peter ^d   Emond, Patrik ^e   Frangin, Yves ^e   Guilloteau, Denis ^e   Gysemans, Marielle ^f   Holschbach, Marcus ^a   Loc'H, Christian ^c   Schubiger, August P ^d   Qaim, Syed M ^a  

^a FORSCHUNGSZENTRUM JÜLICH   (Germany)

^b BEFY NUGE Radiopharmaceutical Chemistry   (Belgium)

^c DIF   (France)

^d PAUL SCHERRER INSTITUTE   (Switzerland)

^e CHU BRETONNEAU   (France)

^f BELGIAN NUCLEAR RESEARCH CENTRE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84889854175     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/1-4020-4561-1     Document Type: Book

References (343)

1. Browne E, Firestone RB (1986) Table of Radioactive Isotopes. Wiley, New York
2. 120Te (p, n)-process at a small-sized cyclotron. Appl Radiat Isot 49:1493-1496
3. Sajjad M, Lambrecht RM, Bakr SA (1988) Chromatographic evaluation of the radiochemical purity of reductant-free iodine-123. Nucl Med Biol 15:721-722
4. 123I iodide. Radiochim Acta 50:123-127
5. Sartor J, Guhlke S, Tentler M, Biersack HJ (1998) A simple and efficient method for purification and reduction of radioiodine for pharmaceutical syntheses. J Nucl Med 39:143P
6. 120gI. Appl Radiat Isot 49:93-98
7. 122I generator for remote radio-iodinations. Appl Radiat Isot 37:258-260
8. 122I generator system using highly enriched 124Xe and a medium size cyclotron. Appl Radiat Isot 42:229-233
9. Qaim SM, Stöcklin G (1983) Production of some medically important short-lived neutron-deficient radioisotopes of halogens. Radiochim Acta 34:25-40
10. Firouzbakht ML, Teng RR, Schyer DJ, Wolf AP (1987) Production of high purity iodine-123 from Xe-124 at energies between 15 and 34 MeV. Radiochim Acta 41:1-4
11. 124Xe. Appl Radiat Isot 42:221-228
12. Scholten B, Qaim SM, Stöcklin G (1989) Excitation functions of proton induced nuclear reactions on natural tellurium and enriched 123Te: production of 123I via the 123Te (p, n) 123I process at a low-energy cyclotron. Appl Radiat Isot 40:127-132
13. Lambrecht RM, Sajjad M, Qureshi MA, Al-Yanbawi SJ (1988) Production of 124I. J Radioanal Nucl Chem Lett 127:143
14. 124I. J Radioanal Nucl Chem Lett 213:253
15. 124Te (d, xn) 124 125I reactions from threshold up to 14 MeV: comparative evaluation of nuclear routes for the production of 124I. Appl Radiat Isot 55:303-308
16. 124, 123I reactions from 6 to 31 MeV with special reference to the production of 124I at a small cyclotron. Appl Radiat Isot 46:255-259
17. Sheh Y, Koziorowski J, Balatoni J, Lom C, Dahl JR, Finn RD (2000) Low energy cyclotron production and chemical separation of "no carrier added" iodine-124 from a reusable, enriched tellurium-124 dioxide/aluminum oxide solid solution target. Radiochim Acta 88:169-173
18. 120gI at a small-sized cyclotron. Appl Radiat Isot 58:69-78
19. 124I. Appl Radiat Isot 55:149-156
20. Mani RS (1983) Reactor-produced radionuclides. In: Helus F (ed) Radionuclides Production. CRC Press, Boca Raton, Florida, p 1-45
21. Manual for reactor produced radioisotopes (2003), IAEA-TECDOC-1340, p 1-254
22. Braker AH, Moet FP, Van der Zwart RE, Eersels JLH, Herscheid JDM (2002) Adsorption of radioiodine on platinum: a fast and simple column method to obtain concentrated and pure radioiodide in either water or anhydrous solvents, Appl Radiat Isot 57:475-482
23. Kennard O (1976) Bond lengths between carbon and other elements. In: Weast RC (ed) Handbook of Chemistry and Physics. CRC Press, Cleveland Ohio, p F-215
24. Vogel P (1997) Les intermédiaires réactifs. In: De Boeck, Larcier (eds) Chimie Organique. De Boeck Université, Bruxelles, p 316-331
25. Neumeyer JL, Tamagnan G, Wang SY, Gao YG, Millius RA, Kula NS, Baldessarini RJ (1996) N-substituted analogs of 2β-carbomethoxy-3β- (4'-iodophenyl) tropane (β-CIT) with selective affinity to dopamine or serotonin transporters in rat forebrain. J Med Chem 39:543-548
26. Goodman MM, Kung MP, Kabalka GW, Kung HF, Switzer R (2002) Synthesis and characterization of radioiodinated N-(3-iodopropen-1-yl)-2β-carbomethoxy- 3β-(4-chlorophenyl) tropanes: potential dopamine reuptake site imaging agents. J Med Chem 37:1535-1542
27. Frangin Y, Caillet M, Chalon S (1990) A new method to prepare no-carrier-added iodinated spirodecanone derivatives: applications to dopaminergic and serotoninergic ligands. J Label Comp Radiopharm 28:1363-1373
28. Hamant S, Mathieu J-P, Morin C, Trimcev I, Vidal M (1994) The β-iodoethyl group: a stable unit for radioiodination. Bioorg Med Chem Lett 4:1687-1690
29. Rossouw N, Coenen HH (2003) Radiosynthesis and in vitro evaluation of various rodioiodine-labelled β-iodoalkylether prosthetic groups linked to model compounds. Nucl Med Biol 30:373-380
30. van der Waals' radii in angström. In: Weast RC (ed) Handbook of Chemistry and Physics, 70th Edition (1989-1990). CRC Press, Cleveland Ohio, p D-190
31. Wells PR (1968) Group electronegativities. Prog Phys Org Chem 6:111-145
32. Pauling L (2002) The Nature of the Chemical Bond. Cornell University Press, Ithaca
33. 2. A convenient synthesis of 2-deoxy-2-fluoro-D-glucose. J Org Chem 42:1154-1161
34. Fowler JS, Lade RE, MacGregor RR, Shiue C, Wan CN, Wolf AP (1980) Agents for the armamentorium of regional metabolic measurement in vivo via metabolic trapping: 11C-2-deoxy-D-glucose and halogenated glucose derivatives. J Label Comp Radiopharm 19:7-9
35. Goodman MM, Kabalka GW, Meng X, Daniel GB, Longford CPD (1991) Synthesis of iodine-123 labeled 4-O-(E)-3-iodopropen-2-yl-deoxy-D-glucose and 4-O-(E)-3-iodopropen-2-yl-D-glucose as potential brain and heart imaging agents. J Label Comp Radiopharm 30:280-282
36. Kloster G, Laufer P, Wutz W, Stöcklin G (1983) 75 77Br-and 123I-analogues of D-glucose as potential tracers for glucose utilization in heart and brain. Eur J Nucl Med 8:237-241
37. Magata Y, Saji H, Arano Y, Horiuchi K, Torizuka K, Yokohama A (1987) Procurement of radioiodinated glucose derivative and its biological character. Nucl Med Biol 14:7-13
38. Magata Y, Inagaki M, Ohmono Y, Yamada Y, Saji H, Yokohama A (1991) Synthesis and biological evalution of esterified radioiodinated glucose derivative. J Label Comp Radiopharm 30:300-301
39. Goodman MM, Kabalka GW, Meng X, Daniel GB, Longford CPD (1990) Synthesis and evaluation of radioiodinated 4-O-(E)-3-iodopropen-2-yl-D-glucose and derivatives as potential heart imaging agents. J Nucl Med 31:900
40. Goodman MM, Kabalka GW, Waterhouse RN, Daniel GB (1991) Synthesis of iodine-123 labeled 3-O-(E)-3-iodopropen-2-yl-D-glucose: a potential new agent for the assesment of glucose transport into the brain and heart using SPECT. J Label Comp Radiopharm 30:278-279
41. 125I]- iodomazindol: a potential tool for SPECT exploration. J Label Comp Radiopharm 34:487-497
42. Galinier E, Garreau L, Dognon AM, Ombettagoka JE, Frangin Y, Chalon S, Besnard JC, Guilloteau D (1993) Synthesis of halogenated analogs of 5-(4-chlorophenyl) - 2, 3-dihydro-5-hydroxy-5H-imidazol[2, 1a]-isoindole or mazindol for exploration of the dopamine transporter. Eur J Med Chem 28:927-933
43. Hansch C, Léo A, Taft RW (1991) A survey of Hammet substituent constants and resonance and field parameters. Chem Rev 91:165-195
44. Bromilow J, Brownlee RTC, Lopez VO, Taft RW (1979) Para-substituent C-13 chemical shifts in substituted benzenes. 1. Updating the σR0 scale and analysis of aprotic solvent effects. J Org Chem 44:4766-4770
45. Léo A, Hansch C, Elkins D (1971) Partition coefficients and their uses. Chem Rev 71:525-616
46. McCall JM (1975) Liquid-liquid partition coefficients by high-pressure liquid chromatography. J Med Chem 18:549-552
47. Unger SH, Feuerman TF (1979) Octanol-aqueous partition distribution and ionization coefficients of lipophilic acids and their anions by reversed-phase high-performance liquid chromatography. J Chromatogr 176:426-429
48. Mertens J, Gysemans M, Bossuyt-Piron C, Thomas M (1990) High yield preparation of pure 2-radioiodoketanserin of high specific activity, a serotonin S2 receptor tracer for SPECT. J Label Comp Radiopharm 28:731-737
49. Mertens J (1991) Clustered lipophilic compensation: a new concept in the development of lipophilic radioiodinated and brominated receptor tracers. J Label Comp Radiopharm 30:363
50. Rekker RF (1978) The hydrophobic fragmental constant. Elsevier North Holland, New York
51. Nys GG, Rekker RF (1974) The concept of hydrophobic fragmental constants (f-values) II. Extension of its applicability to the calculation of lipophilicity of aromatic and heteroaromatic structures. Eur J Med Chem Chim Ther 9:361-376
52. Coenen HH (1994) Radiopharmazeutische Chemie: Grundlagen zur in vivo Untersuchung molekularer VorgÄnge mit PET. der Nuklearmediziner 17:203-214
53. Hansch C, Léo A (1979) Substituent constants for correlation analysis. Wiley Interscience, New York
54. Deutzmann R, Stöcklin G (1981) Chemical effects of iodine-125 decay in aqueous solution of 5-iodouracil. Ring fragmentation as a consequence of the Auger-effect. Radiat Res 87:24-36
55. Stöcklin G (1977) Bromine-77 and iodine-123 radiopharmaceuticals. J Appl Radiat Isot 28:131-147
56. Seevers RH, Counsell RE (1982) Radioiodination techniques for small organic molecules. Chem Rev 82:575-590
57. Coenen HH, Moerlein SM, Stöcklin G (1983) No-carrier-added radiohalogenation methods with heavy halogens. Radiochim Acta 34:47-68
58. Coenen HH (1986) New radiohalogenation methods: an overview. In: Cox PH, Mather SJ, Sambson CB, Lazarus CR (eds) Progress in Radiopharmacy Development in Nuclear Medicine 10. Martinus Nijhoff Publishers, Dordrecht, p 196-220
59. Grassi J, Pradelles P (1987) Radioiodination and other labelling techniques. In: Patrono C, Peskar PA (eds) Handbook of Experimental Pharmacology. Springer-Verlag, Berlin Heidelberg New York, p 91-141
60. Dewanjee MK. (1992) Radioiodination: Theory, Practice and Biomedical Applications. Kluwer Academic Publishers, Boston
61. Machulla HJ, Dutschka K, Astfalk C (1981) Improved synthesis of 17-123I-heptadecanoic acid for routine preparation. Radiochem Radioanal Lett 47:189-192
62. Seevers RH, Counsell RE (1982) Radioiodination techniques for small organic molecules. Chem Rev 82:575-590
63. Counsell RE, Ranade VV, Blair RJ, Beierwaltes WH, Weinhold PA (1970) Tumor localizing agents. IX. Radioiodinated cholesterol. Steroids 16:317-328
64. Counsell RE, Kulkarni PG, Afiatpour P, Ranade VV (1973) Potential organ-or tumor-imaging agents. 13. 19-Radioiodinated sterols. J Med Chem 16:945-947
65. Blair RJ, Beierwaltes WH, Lieberman LM, Boyd CM, Counsell RE, Weinhold PA, Varma VM (1971) Radiolabeled cholesterol as an adrenal scanning agent. J Nucl Med 1:176-182
66. Tubis M, Endow JS, Blahd WH (1967) The preparation of 131-I labeled diethylstilbestrol diphosphate and its potential use in nuclear medicine. Nucl Med 6:1-15
67. 131I-iodomethyl-19- norcholest-5 (10)-en-3β-ol (NP-59). J Label Comp Radiopharm 11:427-434
68. 11C-2-deoxy-D-glucose and halogenated deoxyglucose derivatives. J Label Comp Radiopharm 16:7-9
69. Robinson GD Jr, Zielinski FW (1977) Preparation of I-123 labeled 16-iodo-9-hexadecenoic acid and derivatives for heart perfusion imaging. J Label Comp Radiopharm 13:220
70. Robinson GD Jr, Lee AW (1979) Reinvestigation of the preparation of 131I-4-iodoantipyrine from 131I-iodide. Int J Appl Radiat Isot 30:365-367
71. Riche F, Mathieu JP, Vincens M, Bardy A, Comet M, Vidal M (1984) Acides gras marqués en position ς par un nucléide radioactif émetteur gamma. Bull Soc Chim Fr 1149-1155
72. Fagret D, Bontemps L, Apparu M, Keriel C, Mathieu JP, Pernin C, Vidal M, Comet M, Cuchet P (1985) Kinetics of iodomethylated hexadecanoic acid metabolism in the rat myocardium: influence of the number and the position of methyl radicals. Int J Nucl Med Biol 12:363-367
73. Srivastava PC, Lambert CR, Allred JF, Kennel SJ, Hasan A (1990) I-125 labeled azomycin acyclonucleoside: design and synthesis of an attractive misonidazole analogue for imaging hypoxia. J Nucl Med 31:900
74. Srivastava PC, Hasan A, Buchsbaum DJ (1991) Iodoazomycin acyclonucleoside: a potential SPECT imaging agent with high tumor uptake. J Label Comp Radiopharm 30:424-425
75. Robinson GD Jr, Lee AW (1975) Radioiodinated fatty acids for heart imaging: iodine monochloride addition compared with iodide replacement labeling. J Nucl Med 16:17-21
76. 123I-16-iodo-9-hexadecenoic acid and derivatives for use as myocardial perfusion imaging agents. Int J Appl Radiat Isot 28:149-156
77. Machulla HJ, Stöcklin G, Kupfernagel C, Freundlieb C, Höck A, Vyska K, Feinendegen LE (1978) Comparative evaluation of fatty acids labeled with C-11, Cl-34m, Br-77, and I-123 for metabolic studies of the myocardium: concise communication. J Nucl Med 19:298-302
78. 123I-phenyl)- pentadecanoic acid. J Radioanal Chem 65:123-130
79. Mertens J, Vanryckeghem W, Bossuyt A, Van Den Winkel P, Vandendriessche R (1984) Fast low temperature ultrasonic synthesis and injection ready preparation of carrier free 17-I-123-heptadecanoic acid. J Label Comp Radiopharm 21:843-856
80. Hochberg RB (1979) Iodine-125-labeled estradiol: a gamma-emitting analog of estradiol that binds to the estrogen receptor. Science 205:1138-1140
81. 125I]iodo-estradiol with estrogen receptor and other steroid-binding proteins. Proc Nat Acad Sci USA 77:328-332
82. 123I: concise communication. J Nucl Med 17:1093-1095
83. 125I]16α-iodoestradiol: effect on estrogen receptor-mediated target tissue uptake. J Label Comp Radiopharm 30:439-441
84. Miller J (1968) Aromatic Nucleophilic Substitution. Elsevier, New York
85. Mangner TJ, Wu JI, Wieland DM (1982) Solid-phase exchange radioiodination of aryl iodides. Facilitation by ammonium sulfate. J Org Chem 47:1484-1488
86. Guilloteau D, Baulieu JL, Viel C, Valat C, Baulieu F, Chambon-Deschamps C, Pourcelot L, Itti R, Besnard JC (1983) Etude préliminaire d'un marqueur de la médullo-surrénale et des terminaisons sympathiques: la méta-iodobenzylguanidine. J Biophys Méd Nucl 7:117-122
87. Wafelman AR, Konings MC, Hoefnagel CA, Maes RA, Beijnen JH (1994) Synthesis, radiolabelling and stability of radioiodinated m-iodobenzylguanidine, a review. Appl Radiat Isot 45:997-1107
88. Taplin GV, Meredith OM Jr, Kade H (1955) The radioactive (I-131-tagged) rose bengal uptake-excretion test for liver function using external gamma-ray scintillation counting techniques. J Lab Clin Med 45:665-678
89. Hupf HB, Wanek PM, O'Brien HA Jr, Holland LM (1978) Rapid radioiodination of rose bengal at room temperature. J Nucl Med 19:525-529
90. Tubis M, Posnick E, Nordyke RA (1960) Preparation and use of I-131 labeled sodium iodohippurate in kidney function tests. Proc Soc Exp Biol 103:497-498
91. Elias H, Arnold C, Kloss G (1973) Preparation of 131-I-Labelled m-iodohippuric acid and its behaviour in kidney function studies compared to o-iodohippuric acid. Int J Appl Radiat Isot 24:463-469
92. Counsell RE, Pocha P, Ranade VV, Sterngold J, Beierwaltes WH (1969) Tumor localizing agents. VII. Radioiodinated quinoline derivatives. J Med Chem 12:232-236
93. Packer S, Redvanly C, Lambrecht RM, Wolf AP, Atkins HL (1975) Quinoline analog labeled with iodine 123 in melanoma detection. Arch Ophthalmol 93:504-508
94. Bakker CNM, Kaspersen FM (1979) The labeling of 4-alkylamino- iodoquinolines with radioactive iodine by isotopic exchange. J Label Comp Radiopharm 16:917-928
95. Thakur ML (1974) The preparation of iodine-123 labelled contrast agents. Int J Appl Radiat Isot 25:576-578
96. Wieland DM, Swanson DP, Brown LE, Beierwaltes WH (1979) Imaging the adrenal medulla with an I-131-labeled antiadrenergic agent. J Nucl Med 20:155-158
97. Winchell HS, Baldwin RM, Lin TH (1980) Development of I-123-labeled amines for brain studies: localization of I-123-iodophenylalkyl amines in rat brain. J Nucl Med 21:940-946
98. Kung HF, Tramposch KM, Blau M (1983) A new brain perfusion imaging agent: [I-123]HIPDM:N, N, N'-trimethyl-N'-[2-hydroxy-3-methyl-5-iodobenzyl]-1, 3-propanediamine. J Nucl Med 24:66-72
99. Lui B, Chang J, Sun JS, Billings J, Steves A, Ackerhalt R, Molnar M, Kung HF (1987) Radioactive iodine exchange reaction of HIPDM: kinetics and mechanism. J Nucl Med 28:360-365
100. Nakatsuka I, Shimizu HSK, Yoshitake A (1986) Novel radioactive iodospiroperidol and process for its preparation. European Patent Application 0187:162
101. Van Dort ME, Chakraborty PK, Wieland DM, Kilbourn M (1990) Dopamine uptake inhibitors: comparison of 125I-and 18F-labeled ligands. J Nucl Med 31:898-899
102. Van Dort ME, Gildersleeve DL, Wieland DM (1991) Radioiodinated presynaptic markers for GABA and dopaminergic neurons. J Label Comp Radiopharm 30:271
103. Jung YW, Van Dort ME, Wieland DM (1990) Presynaptic cholinergic marker: (±)-I-125-iodobenzovesamicol. J Nucl Med 31:797
104. Jung YW, Van Dort ME, Gildersleeve DL, Wieland DM (1990) A radiotracer for mapping cholinergic neurons of the brain. J Med Chem 33:2065-2068
105. Jung YW, Van Dort ME, Wieland DM (1991) Synthesis of (±)-I-125- iodobenzovesamicol: a cholinergic neuron marker. J Label Comp Radiopharm 30:387-388
106. 123I]-iodo-PK11195 for mapping peripheral-type benzodiazepine receptors (omega 3) in heart. Nucl Med Biol 23:23-28
107. Rafii H, Chalon S, Ombetta JE, Frangin Y, Pourcelot L, Besnard JC, Bodard S, Guilloteau D (1996) An iodinated derivative of moclobemide as potential radioligand for brain MAO-A exploration. Life Sci 58:1159-1169
108. Beer HF, Blauenstein PA, Hasler PH, Delaloye B, Riccabona G, Bangerl I, Hunkeler W, Bonetti EP, Pieri L, Richards JG (1990) In vitro and in vivo evaluation of iodine-123-Ro 16-0154: a new imaging agent for SPECT investigations of benzodiazepine receptors. J Nucl Med 31:1007-1014
109. Saji H, Iida Y, Nakatsuka I, Yoshitake A, Magata Y, Yokoyama A (1991) New radioiodinated ligand for SPECT studies of benzodiazepine receptor. J Label Comp Radiopharm 30:238-239
110. 123I]-labelled compounds to study the dopamine system of the brain. J Label Comp Radiopharm 30:277
111. 125I]N-(2-aminoethyl)-4-iodobenzamide as a selective monoamine oxidase B inhibitor. Nucl Med Biol 22:617-623
112. 25I]iodo-2'-deoxyuridine in rat brain tumors: diagnostic and therapeutic implications in humans. Cancer Res 50:5199-5203
113. Gildersleeve DL, Lin TY, Wieland DM, Ciliax BJ, Olson JM, Young AB (1989) Synthesis of a high specific activity 125I-labeled analog of PK 11195, potential agent for SPECT imaging of the peripheral benzodiazepine binding site. Int J Rad Appl Instrum B 16:423-429
114. Chalon S, Pellevoisin C, Bodard S, Vilar MP, Besnard JC, Guilloteau D (1996) Iodinated PK 11195 as an ex vivo marker of neuronal injury in the lesioned rat brain. Synapse 24:334-339
115. Bacon RGR, Hill HAO (1964) Metal ions and complexes in organic reactions. I. Substitution reactions between aryl halides and cuprous salts in organic solvents. J Chem Soc 1097-1107
116. 131I]]meta-iodobenzylguanidine (MIBG) using Cu (I) generated "in situ" by sodium disulphite. Appl Radiat Isot 43:737-740
117. Moerlein S, Hwang DR, Welch MJ (1988) No-carrier-added radiobromination via cuprous chloride-assisted nucleophilic aromatic bromodeiodination. Appl Radiat Isot 39:369-372
118. Moerlein S (1990) Regiospecific aromatic radioiodination via no-carrier-added copper (I) chloride-assisted radioiodination. Radiochim Acta 50:55-61
119. Moerlein SM, Hwang DR, Welch MJ (1988) No-carrier-added radiobromination via cuprous chloride-assisted nucleophilic aromatic bromodeiodination. Int J Rad Appl Instrum A 39:369-372
120. 123I radioiodination of 15 (p-I-phenyl)-9-methyl pentadecanoic acid, a potential myocardial tracer. Eur J Nucl Med 13:159-160
121. Coenen HH, Dutschka KP, Brandau W (1994) N.c.a. Cu (I)-assisted iodine-exchange on N-alkylated ortho-, meta-, and para-bromobenzamides. J Label Comp Radiopharm 35:222-223
122. Tarle M, Padovan R, Spaventi S (1978) Radioiodination of iodinated estradiol-17-diphosphates. J Label Comp Radiopharm 15:7-21
123. Mertens J, Vanryckeghem W (1985) Fast quantitative labelling of N-isopropyl-piodo-amphetamine with I-123 in presence of Cu (I) and ascorbic acid, allowing kitform preparation. In: IAEA (ed) Radiopharmaceuticals and Labelled Compounds. IAEA, Vienna, p 303-310
124. Mertens J, Vanryckeghem W, Carlsen L (1986) Cu (I) supported isotopic exchange of arylbound iodide, new future for fast high yield labelling. In: Cox PH (ed) Progress in Radiopharmacy. Nijhoff M. Publisher, Dordrecht, p 101-109
125. Mertens J, Gysemans M, Piron C (1990) High yield preparation of pure 2-radioiodoketanserin of high specific activity. A serotonin S2 receptor tracer for SPECT. J Label Comp Radiopharm 28:732-738
126. 123I-labelled radiopharmaceuticals. Eur J Nucl Med 13:380-381
127. Stanko VI, Iroshnikova NG, Volkov AF, Klimova AI (1984) Copper catalysis on isotopic exchange as a novel approach to incorporating iodine and bromine into benzene derivatives. Int J Radiat Isot 35:1129-1132
128. Iroshnikova NG, Klimova TP, Stanko VI (1973) A method to produce meta-and para-iodobenzoic acids labelled with iodine isotopes. Isotopenpraxis 9:50-54
129. Brandau W, Pulawski P, Niehoff T, Coenen HH, Dutschka K, Kirchner B, Schober O (1995) Melanoma imaging agents: synthesis, labelling and pharmacokinetics of I-123-iodobenzamides. J Nucl Med 36:116P
130. Schirbel A, Coenen HH (1995) Comparison of non-isotopic exchange methods for n. c.a. labelling of 2-iodophenylmetyrapone. Nucl Med Biol 22:1075-1079
131. Brandau W, Niehoff T, Pulawski P, Jonas M, Dutschka K, Sciuk J, Coenen HH, Schober O (1996) Structure distribution relationship of iodine-123- iodobenzamides as tracers for the detection of melanotic melanoma. J Nucl Med 37:1865-1871
132. 1+-assisted nucleophilic exchange radiohalogenation: application and mechanistic approach. In: Emram AM (ed) New Trends in Radiopharmaceutical Synthesis, Quality Assurance and Regulation Control. Plenum Press, New York, p 53-65
133. 131I]]iodobenzamides by animal and cell-culture studies. J Label Comp Radiopharm 37:260-262
134. Hennecken H, Krummeich C, Holschbach M, Stöcklin G (1995) Copper (I)-assisted n. c.a. radioiodo-debromination using cuprous sulfate; radioiodination of reduction sesitive 2-nitroimidazole amino acid conjugates. J Label Comp Radiopharm 37:208-210
135. Mertens J, Callaerts A, Vanryckeghem W (1986) New realistic approach of the kinetics in fast labelling procedures. J Label Comp Radiopharm 24:607-612
136. Guilloteau D, Lena I, Ombetta JE, Garreau L, Besnard JC (1993) Synthesis and characterization of a iodopargyline. A potential ligand for SPECT study of brain monoamine oxidase. J Nucl Med 34:235P-236P
137. Lena I, Ombetta JE, Chalon S, Dognon AM, Baulieu JL, Frangin Y, Garreau L, Besnard JC, Guilloteau D (1995) Iododerivative of pargyline: a potential tracer for the exploration of monoamine oxidase sites by SPECT. Nucl Med Biol 22:727-736
138. Mertens J, Gysemans M, Bossuyt-Piron C, Thomas M (1990) High yield preparation of pure 2-radioiodoketanserin of high specific activity, a serotonin S2 receptor tracer for SPECT. J Label Comp Radiopharm 28:731-737
139. 125I]- iodomazindol: a potential tool for SPECT explorations. J Label Comp Radiopharm 34:487-497
140. 131I]]iodotropapride: a cerebral dopamine D2 receptor ligand. J Label Comp Radiopharm 30:360-361
141. Foulon C, Garreau L, Chalon S, Desplanches G, Frangin Y, Besnard JC, Baulieu JL, Guilloteau D (1992) Synthesis and in vitro binding properties of halogenated analogues of GBR as new dopamine uptake carrier ligands. Nucl Med Biol 19:597-600
142. Branger C, Garreau L, Dognon AM, Frangin Y, Caillet M, Ombetta-Goka JE, Chalon S, Besnard JC, Guilloteau D (1995) Synthesis of 4'-iodo-5-methoxy- valerophenone O-(2-aminoethyl) oxime as an agent for exploration of serotoninergic transporter. Nucl Med Biol 22:157-164
143. 125I]iodo-benzylamine as potential tools for monoamine uptake exploration by SPECT. J Label Comp Radiopharm 36:685-699
144. Ceusters M, Tourwé D, Callaerts J, Mertens J, Peter A (1995) New single-step radioiodination technique for peptides: Cu (I) catalyzed nucleophilic nonisotopic displacement reaction. Synthesis of radioiodinated deltorphin and dermorphin analogues. J Org Chem 60:8324-8326
145. 123 124I]beta-CIT, plasma analysis and pharmacokinetic studies with SPECT and PET. Nucl Med Biol 22:977-984
146. Shiba K, Mori H, Matsuda H, Tsuji S, Kuji I, Sumiya H, Kinuya K, Tonami N, Hisada K, Sumiyosi T (1995) Synthesis of radioiodinated analogs of 2-(4-phenylpiperidino) cyclohexanol (vesamicol) as vesamicol-like agent. Nucl Med Biol 22:205-210
147. 123I]iodobenzoyl)-1, 3, 8-triazaspiro[4, 5]decan-4-one: a novel selective serotonin 5-HT2 receptor agent. Nucl Med Biol 24:295-303
148. Michelot JM, Moreau MF, Labarre PG, Madelmont JC, Veyre AJ, Papon JM, Parry DF, Bonafous JF, Boire JY, Desplanches GG (1991) Synthesis and evaluation of new iodine-125 radiopharmaceuticals as potential tracers for malignant melanoma. J Nucl Med 32:1573-1580
149. Wanek PM (1981) Notes on the radioiodination of hippuric acid. Radiochem Radioanal Lett 466:401-404
150. 123I-iodo- hippuric acid. Eur J Nucl Med 7:58-61
151. Magata Y, Saji H, Arano Y, Horiuchi K, Torizuka K, Yokoyama A (1987) Procurement of radioiodinated glucose derivative and its biological character. Int J Rad Appl Instrum B 14:7-13
152. Magata Y, Inagaki M, Ohmomo Y, Yamada Y, Saji H, Yokoyama A (1991) Synthesis and biological evaluation of esterified radioiodinated glucose derivative. J Label Comp Radiopharm 30:300-301
153. 131I]-labelled N-isopropyl-p-iodoamphetamine. Eur J Nucl Med 7:280-281
154. Michelot JM, Moreau MF, Veyre AJ, Bonafous JF, Bacin FJ, Madelmont JC, Bussiere F, Souteyrand PA, Mauclaire LP, Chossat FM (1993) Phase II scintigraphic clinical trial of malignant melanoma and metastases with iodine-123-N-(2-diethylaminoethyl-4-iodobenzamide). J Nucl Med 34:1260-1266
155. Moreau MF, Michelot J, Papon J, Bayle M, Labarre P, Madelmont JC, Parry D, Boire JY, Moins N, Seguin H, Veyre A, Mauclaire L (1995) Synthesis, radiolabeling, and preliminary evaluation in mice of some (N-diethylaminoethyl) - 4-iodobenzamide derivatives as melanoma imaging agents. Nucl Med Biol 22:737-747
156. 125I]-iodobenzamide, a promising tracer for detection of melanoma. J Label Comp Radiopharm 41:965-975
157. Saji H, Iida Y, Nakatsuka I, Kataoka M, Ariyoshi K, Magata Y, Yoshitake A, Yokoyama A (1993) Radioiodinated 2'-iododiazepam: a potential imaging agent for SPECT investigations of benzodiazepine receptors. J Nucl Med 34:932-937
158. 123I-labelled reversible inhibitors of monoamine oxidase B. Nucl Med Biol 25:47-52
159. Coenen HH, Moerlein SM, Stöcklin G (1983) No-carrier-added radiohalogenation methods with heavy halogens. Radiochim Acta 34:47-68
160. Coenen HH (1986) New radiohalogenation methods: an overview. In: Cox PH, Mather SJ, Sambson CB, Lazarus CR (eds) Progress in Radiopharmacy Development in Nuclear Medicine. Martinus Nijhoff Publishers, Dordrecht, p 196-220
161. Cardoso MT, Pradelles P (1982) Preparation of N-(1-ethyl-2-pyrrolidyl- methyl)-2-methoxy-4-125I-5-ethylsulfonyl benzamide: a radioligand for the radioimmunoassay of sulpiride-related compounds. J Label Comp Radiopharm 19:1103-1109
162. Foster NI, Heindel ND, Burns HD, Muhr W (1980) Aryl iodides from anilines via triazene intermediates. Synthesis 1:572-573
163. Ku H, Barrio JR (1981) Convenient synthesis of aryl halides fromarylamines via treatment of 1-aryl-3, 3-dialkyltriazenes with trimethylsilyl halides. J Org Chem 46:5239-5241
164. Goodman MM, Knapp FF, Callahan AP, Ferren LA (1982) Radioiodinated 15-(piodophenyl)-6-tellurapentadecanoic acid: a new agent showing prolonged myocardial retention. J Nucl Med 23:P104
165. Goodman MM, Knapp FF Jr, Elmaleh DR, Strauss HW (1984) New myocardial imaging agents: synthesis of 15-(p-iodophenyl)-3 (R, S)-methylpentadecanoic acid by decomposition of a 3, 3-(1, 5-pentanediyl) triazene precursor. J Org Chem 49:2322-2325
166. 125I]iodo-2- methoxybenzamide hydrochloride, a new selective radioligand for dopamine D2 receptors. J Med Chem 31:2027-2033
167. Foster NI, Dannals R, Burns HD, Heindel ND (1981) A condition variation study for radioiodination via triazene intermediates. J Radioanal Chem 65:95-105
168. 125I]-1-(2, 5-dimethoxy-4-iodophenyl)-2-aminopropane: an iodinated radioligand that specifically labels the agonist high-affinity state of 5-HT2 serotonin receptors. J Med Chem 31:5-7
169. Brückner R (2001) Advanced Organic Chemistry: Reaction mechanisms. Harcourt/Academic Press, San Diego
170. De La Mare P (1976) Electrophilic Halogenation. Cambridge University Press, Cambridge
171. Norman ROC (1965) Electrophilic Substitution in Benzoid Compounds. Elsevier, New York
172. Seevers RH, Counsell RE (1982) Radioiodination techniques for small organic molecules. Chem Rev 82:575-590
173. Doran DM, Spar IL (1980) Oxidative iodine monochloride iodination technique. J Immunol Methods 39:155
174. 123I-iodine-monochloride as iodination reagent for synthesis of radiopharmaceuticals IV. J Nucl Med 13:266-273
175. 2, IBr, ICl. J Lab Comp Radiopharm 37:137-138
176. Thinius O, Dutschka K, Coenen HH (1994) Reactivity of iodine monofluoride on sub-micromolar scale with arenes. Tetrahedron Lett 35:9701-9702
177. 2. J Org Chem 55:3552-3555
178. Hunter WM, Greenwood FC (2002) Preparation of iodine-131 labelled human growth hormone of high specific activity. Nature 194:495-496
179. Jirousek L (1981) On the chemical nature of iodinating species. J Radioanal Chem 65:139-154
180. Coenen HH, Petzold G, Stöcklin G (1982) Recent studies of radiobromination and iodination (n. c.a.) with chloramine-T in aqueous and organic solvents. J Lab Comp Radiopharm 19:1580-1581
181. Stöcklin G (1988) Spezielle Syntheseverfahren mit kurzlebigen Radionukliden und Qualitätskontrolle. In: Emissions-Computertomographie mit kurzlebigen Zyklotronproduzierten Radiopharmaka. Handbuch für medizinischen Radiologie, Vol XV/1b. Springer-Verlag, Berlin Heidelberg New York, p 33-117
182. Coenen HH, Moerlein SM, Stöcklin G (1983) No-carrier-added radiohalogenation methods with heavy halogens. Radiochim Acta 34:47-68
183. Markwell MAK (1982) A new solid-state reagent to iodinate proteins. I. Conditions for the efficient labelling of antiserum. Anal Biochem 125:427-432
184. Petzold GS (1982) Untersuchungenzurelectrophilen Radiobromierung and-iodierung aromatischer Verbindungen mit N-Halogenverbindungen ohne Trägerzusatz. Universität zu Köln und Berichte der Kernforschungsanlage Jülich, Report Jül-1810, ISSN 0366-0885
185. Fraker PI, Speck JC Jr (1978) Protein and cell membrane iodinations with a sparingly soluble chloramide 1, 3, 4, 6-tetrachloro-3αp-6α- diphenylglycouril. Biochem Biophys Res Com 80:849-856
186. Krummeich C, Holschbach M, Stöcklin G (1994) Direct n. c.a. electrophilic radioiodination of tyrosine analogues; their in vivo stability and brain-uptake in mice. Appl Radiat Isot 45:929-935
187. Krummeich C, Holschbach M, Stöcklin G (1996) Convenient direct n. c.a. electrophilic radioiodination of arenes using Iodogen™. Appl Radiat Isot 47:489-495
188. Youfeng H, Coenen HH, Petzold G, Stöcklin G (1982) A comparative study of simple aromatic compounds via N-halosuccinimides and chloramine-T in TFAA. J Lab Comp Radiopharm 19:807-819
189. Mennicke E, Holschbach M, Coenen HH (2000) Electrophilic radioiodination of deactivated arenes with N-chlorosuccinimide. J Lab Comp Radiopharm 43:721-737
190. Moerlein SM, Beyer W, Stöcklin G (1988) No-carrier-added radiobromination and radioiodination of aromatic rings using in situ generated peracetic acid. J Chem Soc Perkin Trans I 3:779-786
191. 123I]iodoa-methyl tyrosine: comparison with PET 124IMT and first clinical results. J Nucl Med 31:281-286
192. 123-125Xe-exposed KIO3, a reagent for iodination with high specific activity. Radiochimica Acta 24:42-46
193. 123I] iodo-α-methyl tyrosine: competition with natural L-amino acids. J Nucl Med 32:1225-1229
194. Mennicke E, Holschbach M, Coenen HH (2000) Direct n. c.a. radioiodination of weakly activated arenes using metal salts. Radiochim Acta 88:221-227
195. Mennicke E, Hennecken H, Holschbach M, Coenen HH (1997) N.c.a. radioiodination of weakly activated arenes using thallium-tris (trifluoroacetate). J Lab Comp Radiopharm 40:107-108
196. Gadek A, Modarkski M (1983) Enzymatic method of incorporation of I-125 into FNA. Arch Immunol Ther Exp 31:541
197. Hadi UAM, Malcome-Lawes DJ, Oldham G (1978) The labelling of small molecules with radioiodine. Int J Appl Radiat Isot 29:621-623
198. Sammon PJ, Stansbury M, Stahr G (1979) Micro-electrolytic iodination of polypeptide hormones. Int J Appl Radiat Isot 30:359-364
199. Teare FW, Rosenberg RA (1978) Micro-electrolytic radioiodination of polypeptide hormones to high specific activity. Int J Appl Radiat Isot 29:567-569
200. Kloss G, Leven M (1979) Accumulation of radioiodinated tyrosine derivatives in the adrenal medulla and in melanomas. Eur J Nucl Med 4:179-186
201. Tisljar U, Kloster G, Ritzl F, Stocklin G (1979) Accumulation of radioiodinated alpha-methyltyrosine in pancreas of mice: concise communication. J Nucl Med 20:973-976
202. Kloster G, Coenen HH, Szabo Z, Ritzl F, Stocklin G (1982) Radiohalogenated L-amethyltyrosines as potential pancreas imaging agents for PET and SPECT. In: Cox PH (ed) Progress in Radiopharmacology. Nijhoff, Den Haag, p 97-107
203. Kung HF, Kasliwal R, Pan S, Kung MP, Mach RH, Guo YZ (1988) Dopamine D2 receptor imaging radiopharmaceuticals: synthesis, radiolabeling, in vitro binding of (R) - (+) - and (S) - (-)-3-iodo-2-hydroxy-6-methoxy-N-[(1-ethyl-2- pyrrolidinyl) methyl]benzamide. J Med Chem 31:1039-1043
204. 2 receptors. J Med Chem 31:2027-2033
205. 2 receptors: synthesis and preliminary in vivo study. Nucl Med Biol 17:389-395
206. Pala A, Marinelli G, D'Intinosante V, DiRuzza A, Carenza L (1982) Preparation of 2-125I-testosterone and its use as ligand for radioimmunoassay in serum. Anal Lett 15:413-426
207. Kabalka GW, Goodman MM (1991) Synthesis of radiopharmaceuticals via organoboranes. In: Emram AM (ed) New Trends in Radiopharmaceutical Synthesis, Quality Assurance and Regulatory Control. Plenum Press, New York, p S289-S301
208. Kabalka GW, Varma RS (1989) The synthesis of radiolabelled compounds via organometallic intermediates. Tetrahedron 45:6601-6621
209. Kabalka GW, Gooch EE (1981) Synthesis of organic iodides via reaction of organoboranes with sodium iodide. J Org Chem 46:2582-2584
210. Kabalka GW, Goodman MM, Maddox JT (1993) The synthesis of radioiodinated vinyl iodides via organoboranes chemistry. J Lab Comp Radiopharm 32:201-203
211. 123I-sodium iodide with organoboranes. Int J Appl Radiat Isot 33:223-224
212. Apparu M, Madelmont JC (1998) Molécules marquées à l'iode radioactif. In: Comet M, Vidal M (eds) Radiopharmaceutiques. Presses Universitaires de Grenoble, Grenoble, p 249-293
213. Moerlein SM, Coenen HH (1985) Regiospecific no-carrier-added radiobromination and radioiodinationn of aryltrimethyl group IVb organometallics. J Chem Soc Perkin Trans I 9:1941-1947
214. Moerlein SM (1985) Regiospecific incorporation of no-carrier-added radiobromine and radioiodine into aromatic rings via halogenodegermylation. J Chem Soc Perkin Trans I 5:1687-1692
215. Moerlein SM, Mathis CA, Yano Y (1987) Comparative evaluation of electrophilic aromatic iododemetallation techniques for labelling radiopharmaceuticals with iodine-122. Appl Radiat Isot 38:85-90
216. 125I] epidepride: a dopamine D2 receptor antagonist radioligand. J Lab Comp Radiopharm 29:745-751
217. 125I]-iodovinyl-2-and -4-fluorooestradiols. J Lab Comp Radiopharm 32:225-227
218. Canney D, Kung MP, Guo YZ, Kung HF (1993) Monoamine storage site imaging agent for SPECT: iodinated tetrabenazine. J Lab Comp Radiopharm 32:199-200
219. 124I-iodo- dexetimide, a potent muscarinic cholinergic receptor antagonist. J Med Chem 32:1057-1062
220. Seibyl JP, Marek K, Sheff K, Baldwin RM, Charney DS, Van Dyck CH, Innis RB (1998) Iodine-123-β-CIT and iodine-123-FPCIT SPECT measurement of dopamine transporters in healthy subjects and Parkinson's patients. J Nucl Med 39:1500-1508
221. Booij J, Habraken JBA, Bergmans P, Tissingh G, Winogrodzka A, Wolters EC, Janssen AGM, Stoof JC, Van Royen EA (1998) Imaging of dopamine transporters with iodine-123-FP-CIT SPECT in healthy controls and patients with Parkinson's disease. J Nucl Med 39:1879-1884
222. Kessler RM, Ansari MS, De Paulis T, Schmidt DE, Clanton JA, Smith HE, Manning RG, Gillespie D, Ebert MH (1991) High affinity dopamine D2 receptor radioligands. 1. Regional rat brain distribution of iodinated benzamides. J Nucl Med 32:1593-1600
223. 123I]-labelled analogues of the partial inverse agonist Ro 15-4513 for the study of diazepam-insensitive benzodiazepine receptors. Nucl Med Biol 26:641-649
224. 123I]iodophenyl) pentadecanoic acid-IPPA via methyl-15-(4- trimethylstannyl phenyl) pentadecanoate. Appl Radiat Isot 48:745-747
225. Pereyre M, Quintard JP, Rahm A (1986) Tin in Organic Synthesis. Butterworths, London
226. Kühnast B, Dollé F, Rousseau B, Pillon F, Vaufrey F, Tavitian B, Crouzel C (1999) Radioiodine labelled oligonucleotides as tool for imaging mRNAs. J Lab Comp Radiopharm 42:S612-S613
227. Jung ME, Light LA (1982) Preparation of iodoallylic alcohols via hydrostannylation: spectroscopic proof of structures. Tetrahedron Lett 23:3851-3854
228. Goodman MM, Kung MP, Kabalka GW, Kung HF (1994) Synthesis and characterization of radioiodinated N-(3-iodopropen-1-yl)-2β-carbomethoxy- 3β-(4-chlorophenyl) tropanes: potential dopamine reuptake site imaging agents. J Nucl Med 37:1535-1542
229. Yu A, Serguchev RB, Gutzulya KRB, Nikitchenko VS (1993) Oxidative halogenation of unsaturated compounds with variable valence metal salts. Khim Zhur 59:1159-1171
230. McKillop A, Fowler JS, Zelesko MJ, Hunt DJ, Taylor EC, McGillivray G (1969) Thallium in organic synthesis. X. A one-step synthesis of aryl iodides. Tetrahedron Lett 29:2427-2430
231. Larock RC (1985) Organomercury Compoundsin Organic Synthesis. Springer-Verlag, Berlin Heidelberg New York
232. 125I]benzoate, a reagent for protein iodination. Int J Appl Radiat Isot 19:703-704
233. Flanagan RJ, Charleson FP, Synnes EI, Wiebe LI (1986) Radiolabelling with organomercury compounds: Part 2. High specific activity synthesis of iodine-125 and iodine-131-6-iodocholest-5-en-3 beta-ol and its tissue distribution in rats. J Nucl Med 27:1165-1171
234. Taylor EC, McKillop A, Atland HW (1975) Thallium in organic synthesis. XXXIX. A convenient synthesis of nitroaryl iodides. J Org Chem 40:3441
235. Braun SL, Dürmeyer E, Vogt KJ, Vogt W (1983) Iodination of aniline using thallium (III)-trifluoroacetate and potassium iodide. Z Naturforsch 38b: 696-697
236. McKillop A, Hunt DJ, Zelesko MJ, Fowler JS, Taylor EC, McGilliv G, Kienzle F (1971) Thallium in organic syhthesis. XXII. Electrophilic aromatic thallation using thallium (III) trifluoroacetate. A simple synthesis of aromatic iodides. J Am Chem Soc 93:4841-4844
237. Ishikawa N, Sekiya A (1974) The iodination of benzene with iodine in the thallium (III) trifluoroacetate-trifluoroacetic acid system. Bull Chem Soc Jpn 47:1680-1682
238. Cambie RC, Rutledge PS, Smith-Palmer T, Woodgate PD (1976) Selective iodination of phenols in the ortho-position. J Chem Soc Perkin Trans I 1161-1164
239. Taylor EC, Kienzle F, Robey RL, McKillop A, Hunt DJ (1971) Thallium in organic synthesis. XXIII. Electrophilic aromatic thallation. Kinetics and applications to orientation control in the synthesis of aromatic iodides. J Am Chem Soc 93:4845-4850
240. Carruthers W, Pooranamoorthy R (1974) 7-, 8-, 9-and 10- methylbenzo[α]fluorene. Preparation of o-iodotoluic acids via thallium (III) bistrifluoroacetates. J Chem Soc Perkin Trans 1:2405-2409
241. Uemura S (1983) Thallium (III) acetate and trifluoroacetate. In: Pizey J (ed) Synthetic Reagents. John Wiley & Son Ltd, New York
242. Carlson GL (1978) Heterogenous iodination of α-cellulose: preparation of a radioactive analog of a dietary fiber. Int J Appl Radiat Isot 29:557-560
243. Uemura S (1987) Preparation and use of organothallium (III) compounds in organic synthesis. In: Hartley FR (ed) The chemistry of metal-carbon bond. John Wiley & son Ltd, New York, p S473-S532
244. Usyantinskii AY, Bregadze VI (1988) Aryl derivatives of thallium (III): preparation and use in organic syhthesis. Rus Chem Rev 57:1054-1068
245. Ferraz HMC, Silva LF, Viera T (1999) Thallium (III) in organic synthesis. Synthesis 12:2001-2023
246. Gilliland DL, Basmadjian GB, Marchand AP, Hinkle GH, Earlywine A, Ice RD (1981) Iodine labelled radiopharmaceuticals from arylthallium bis (trifluoroacetate) intermediates. J Radioanal Chem 65:107-113
247. Mennicke E, Hennecken H, Holschbach M, Coenen HH (1998) Thallium-tris (trifluoracetate): a powerful reagent for the n. c.a. radioiodination of weakly activited arenes. Eur J Nucl Med 25:843
248. Nicholl C, Mohammed A, Hull WE, Bubeck B, Eisenhut M (1997) Pharmacokinetics of iodine-123-IMBA for melanoma imaging. J Nucl Med 38:127-133
249. Sintas JA, Vitale AA (1999) Iodination, radioiodination and spectroscopic identification of β-carboline derivatives. J Lab Comp Radiopharm 42:409
250. Mohammed A, Nicholl C, Titsch U, Eisenhut M (1997) Radioiodinated N-(alkylaminoalkyl)-substituted 4-methoxy-, 4-hydroxy-and 4-aminobenzamides: biological investigations for the improvement of melanoma-imaging agents. Nucl Med Biol 24:373-380
251. Sintas JA, Vitale AA (1998) Synthesis of derivatives of [I-131]phenylalkylamines for brain mapping. J Lab Comp Radiopharm 41:53-61
252. Lin Q, Luo H, Mokler F, Beets AL, Ambrose KR, McPherson DW, Kropp J, Knapp FF (1997) Effects of configuration on the myocardial uptake of radioiodinated 3-(R) - BMIPP and 3 (S)-BMIPP in rats. J Nucl Med 38:1434-1441
253. 131I]]-iodophenyl) hexylamine and its β-and γ-methyl substituted analogues. J Lab Comp Radiopharm 25:383-393
254. 131I]]-iodophenyl) pentylamine and its β-and γ-methyl substituted analogues. J Lab Comp Radiopharm 25:609-620
255. Grassi J, Pradelles P (1987) Radioiodination and other labelling techniques. In: Patrono C, Peskar PA (eds) Handbook of Experimental Pharmacology. Springer-Verlag, Berlin Heidelberg New York, p 91-141
256. Wilbur DS (1992) Radiohalogenation of proteins: an overview of radionuclides, labelling methods, and reagents for conjugate labeling. Bioconjug Chem 3:435-470
257. Behr TM, Gotthardt M, Becker W, Behe M (2002) Radioiodination of monoclonal antibodies, proteins and peptides for diagnosis and therapy. A review of standardized, reliable and safe procedures for clinical grade levels kBq to GBq in the Gottingen/Marburg experience. Nuklearmedizin 41:71-79
258. Regoeczi E (1984) Reactivities of amino acids and proteins with iodine. Iodine-labeled plasma proteins. CRC Press, New York, p 127-213
259. Haubner R, Wester HJ, Reuning U, Senekowitsch-Schmidtke R, Diefenbach B, Kessler H, Stöcklin G, Schwaiger M (1999) Radiolabeled alpha (v) beta3 integrin antagonists: a new class of tracers for tumor targeting. J Nucl Med 40:1061-1071
260. Knight LC, Welch MJ (1978) Sites of direct and indirect halogenation of albumin. Biochim Biophys Acta 543:185-195
261. McFarlane AS (1958) Efficient trace-labelling of proteins with iodine. Nature 182:53
262. Helmkamp RW, Goodland RL, Bale WF, Spar IL, Mutschler LE (1960) High specific activity iodination of γ-globulin with iodine-131 monochloride. Cancer Res 20:1495-1500
263. Samols E, Williams HS (1961) Trace labelling of insulin with iodine. Nature 190:1211-1212
264. Doran D, Spar IL (1980) Oxidative iodine monochloride iodination technique. J Immunol Methods 39:155-163
265. 131I]-labelling of proteins by the iodine monochloride method. Int J Appl Radiat Isot 18:737-746
266. 131I]-labelled human growth hormone of high specific radioactivity. Biochem J 89:114-123
267. Hunter WM, Greenwood FC (1962) Preparation of iodine-131 labelled human growth hormone of high specific activity. Nature 194:495-496
268. Markwell MAK (1982) A new solid-state reagent to iodinate proteins. I. Conditions for the efficient labelling of anti-serum. Anal Biochem 125:427-432
269. Russel J, O'Donoghue JA, Finn R, Koziorowski J, Ruan S, Humm JI, Ling CC (2002) Iodination of annexin V for imaging apoptosis. J Nucl Med 43:671-677
270. Salcinski PRP, McLean C, Sykes JEC, Clement-Jones VV, Lowry PJ (1981) Iodination of proteins, glycoproteins, and peptides using a solid-phase oxidizing agent 1, 3, 4, 6-tetrachloro-3α, 6α-diphenylglycouril (Iodogen). Anal Biochem 117:136-146
271. 131I])-monoclonal antibodies on high-dose labelling in a large reaction volume and temporarily coating the antibody with IODO-GEN. J Nucl Med 42:509-519
272. Thorell JI, Johansson BG (1971) Enzymatic iodination of polypeptides with 125I to high specific activity. Biochim Biophys Acta 251:363-369
273. Seabright PJ, Smith GD (1996) The characterization of endosomal insulin degradation intermediates and their sequence of production. Biochem J 320:947-956
274. Marchalonis JJ (1969) An enzymic method for the trace iodination of immunoglobulins and other proteins. Biochem J 113:299-305
275. Dunford HB (2002) Peroxidase-catalyzed halide ion oxidation. Redox Rep 5:169-171
276. Karonen SL (1990) Developments in techniques for radioiodination of peptide hormones and other proteins. Scand J Clin Lab Invest Suppl 201:135-138
277. Tatum JL, Briner WH, Goodrich JK (1979) Radioiodination of biologically active compounds: a simplified solid-state enzymatic procedure. Invest Radiol 14:185-188
278. Silberring J, Dubin A (1977) Enzymatic iodination of human growth hormone by myeloperoxidase in the solid state. Clin Chim Acta 79:609-610
279. Corrie JET, Hunter WM (1981) 125I-Iodinated tracers for hapten-specific radioimmunoassays. In: Langone JJ, Van Vunakis H (eds) Immunochemical Techniques. Academic Press, New York, p 73-79
280. Zhao Q, Blomquist E, Bolander H, Gedda L, Hartvig P, Janson J, Lundqvist H, Mellstedt H, Nilsson S, Nister M, Sundin A, Tolmachev V, Westlin J, Carlsson J (1998) Conjugate chemistry, iodination and cellular binding of mEGF-dextran-tyrosine: preclinical tests in preparation for clinical trials. Int J Mol Med 1:693-702
281. Wilbur DS, Hamlin DK, Srivastava RR, Burns HD (1993) N-Boc-p-(tri-n- butylstannyl)-L-phenylalanine tetrafluorophenyl ester: preparation of a radiolabelled phenylalanine derivative for peptide synthesis. Bioconjug Chem 4:574-580
282. Brinkley M (1992) A brief survey of methods for preparing conjugates with dyes, haptens, and cross-linking reagents. Bioconjug Chem 3:2-13
283. Bolton AE, Hunter WM (1973) The labelling of proteins to high specific activities by conjugation to a125I-containing acylating agent. Biochem J 133:529-533
284. Langone JJ (1981) Radioiodination by use of the Bolton-Hunter and related reagents. Methods Enzymol 73:113-127.
285. Rudinger J, Ruegg U (1973) Preparation of N-succinimidyl-3 (4-hydroxy-phenyl) propionate. Biochem J 133:538-539
286. 124I]I-SHPP) and its use for the labeling of a VEGF antibody as a PET tracer. J Lab Comp Radiopharm 45:1077-1090
287. Wilbur DS, Jones DS, Fritzberg AR (2002) Synthesis and radioiodination of some aryltin compounds for radiolabelling of monoclonal antibodies. J Lab Comp Radiopharm 23:1304-1306
288. Zalutski MR, Narula AS (1987) A method for the radiohalogenation of proteins resulting in decreased thyroid uptake of radioiodine. Appl Radiat Isot 38:1051-1055
289. Garg PK, Alston KL, Welsh PC, Zalutsky MR (1996) Enhanced binding and inertness to dehalogenation of alpha-melanotropic peptides using N-succinimidyl-3-iodobenzoate. Bioconjug Chem 7:233-239
290. Chen J, Strand SE, Sjogren HO (1996) Optimization of radioiodination and biotinylation of monoclonal antibody chimeric BR96: an indirect labelling using N-succinimidyl-3-(tri-n-butylstannyl) benzoate conjugate. Cancer Biother Radiopharm 11:217-226
291. Garg S, Garg P, Zalutsky MR (1991) N-(Succinimidyl-5-trialkylstannyl)-3- pyridine carboxylates: a new class of reagents for protein radioiodination. Bioconjug Chem 2:50-56
292. Wood FT, Wu MM, Gerhart JJ (1975) The radioactive labelling of proteins with an iodinated amidination reagent. Anal Biochem 69:339-349
293. 125I-labeled imidoester. Anal Biochem 115:287-297
294. Panuska JR, Parker CW (1987) Radioiodination of proteins by reductive alkylation. Anal Biochem 10:192-201
295. Pittman RC, Carew TE, Glass CK, Green SR, Taylor CA, Attie AD (1983) A radioiodinated intracellularly trapped ligand for determining the sites of plasma protein degradation in vivo. Biochem J 212:797-800
296. Ali SA, Eary JF, Warren SD, Krohn KA (1988) Synthesis and radioiodination of tyramine cellobiose for labeling monoclonal antibodies. Nucl Med Biol 15:557-561
297. Geissler F, Anderson SK, Venkatesan P, Press OW (1992) Intracellular catabolism of radiolabeled anti-μ antibodies by malignant B cells. Cancer Res 53:2907-2915
298. Stein R, Goldenberg DM, Thorpe SR, Basu A, Mattes MJ (1995) Effects of radiolabeling monoclonal antibodies with a residualizing iodine radiolabel on the accretion of radioisotope in tumors. Cancer Res 55:3132-3199
299. Reist CJ, Archer GE, Kurpad SN, Wikstrand CJ, Vaidyanathan G, Willingham MC, Moscatello DK, Wong AJ, Bigner DD, Zalutsky MR (1995) Tumor-specific antiepidemal growth factor receptor variant III mboclonal antibodies: use of tyraminecellobiose radioiodination method enhances cellular retention and uptake in tumor xenografts. Cancer Res 55:4375-4382
300. Ram S, Fleming E, Buchsbaum DJ (1992) Development of radioiodinated 3-iodophenylisothiocyanate for coupling to monoclonal antibodies. J Nucl Med 33:1029
301. Ram S, Buchsbaum DJ (1992) Development of 3-iodophenylisocyanate for radioiodination of monoclonal antibodies. Int J Rad Appl Instrum [A] 43:1387-1391
302. Khawli LA, Chen F-M, Alaudin MM, Stein AL (1991) Radioiodinated monoclonal antibody conjugates: synthesis and comparative evaluation. Antibody Immunoconjug Radiopharm 4:163-182
303. Wyeth P, Douglas SG (1984) High activity antibody radioiodination without loss of antigen binding. In: Proceedings of the 5th International Symposium on Radiopharmaceutical Chemistry. Tokyo Japan (ISBN 4-930813-06-9), p 100-101
304. 125I] iodophenyl) maleimide: an agent for high yield radiolabelling of antibodies. Nucl Med Biol 19:289-295
305. 125I]iodobenzoylsucrose, a novel radioactive label for determining organ sites of catabolism of plasma proteins. Biochem J 198:45-51
306. Pandey RN, Wilson JD, Zhao XG, Schlom J (1991) Photolabelling: a new approach to radioiodination. Antibody Immunoconjug Radiopharm 4:399-407
307. 125I]iodophenyl) diarizine, a carbene-generating reagent. Biochemistry 20:7174-7182
308. Dewanjee MK, Kapadvanjwala M, Krishan A, Serafini AM, Ghafouripour AK, Oates EL, Lopez DM, Sfakianakis GN (1993) Radiolabeled antisense oligodeoxynucleotides - in vitro and in vivo applications. J Clin Immunoassay 16:276-289
309. Kühnast B, Dollé F, Terrazzino S, Rousseau B, Loch C, Vaufrey F, Hinnen F, Doignon I, Pillon F, David C, Crouzel C, Tavitian B (2000) General method to label antisense oligonucleotides with radioactive halogens for pharmacological and imaging studies. Bioconjug Chem 11:627-636
310. Reed MW, Panyutin IG, Hamlin D, Lucas DD, Wilbur DS (1997) Synthesis of I-125-labeled oligonucleotides from tributylstannylbenzamide conjugates. Bioconjug Chem 8:238-243
311. Dougan H, Hobbs J, Weitz JL, Lyster DM (1997) Synthesis and radioiodination of a stannyl oligodeoxyribonucleide. Nucleic Acid Res 25:2897-2901
312. Panyutin IG, Neumann R (1996) Sequence-specific DNA breaks produced by triplexdirected decay of iodine-125. Acta Oncol 35:817-823
313. Wafelman AR, Konings MC, Hoefnagel CA, Maes RA, Beijnen JH (1994) Synthesis, radiolabelling and stability of radioiodinated m-iodobenzylguanidine, a review. Appl Radiat Isot 45:997-1007
314. 123I]- Iodophenyl)-tropan-2β-carbonsäure Methylester durch nicht-isotopen, Cu (I) - assistierten Halogenaustausch. Nuklearmedizin 33:A11
315. 123I-labeling and evaluation of Ro 43-0463, a SPET tracer for MAO-B imaging. Nucl Med Biol 22:929-936
316. Brandau W, Niehoff T, Pulawski P, Jonas M, Dutschka K, Sciuk J, Coenen HH, Schober O (1996) Structure distribution relationship of iodine-123- iodobenzamides as tracers for the detection of melanotic melanoma. J Nucl Med 37:1865-1871
317. Dittmann H, Coenen HH, Zölzer F, Dutschka K, Brandau W, Streffer C (1999) In vitro studies on the cellular uptake of melanoma imaging aminoalkyl-iodobenzamide derivatives (ABA). Nucl Med Biol 26:51-56
318. Coenen HH, Dutschka KP, Brandau W (1994) N.c.a. Cu (I)-assisted iodine-exchange on N-alkylated ortho-, meta-, and para-bromobenzamides. J Label Comp Radiopharm 35:222-223
319. Beer HF, Bläuenstein PA, Hasler PH, Delaloye B, Riccabona G, Hunkeler W, Bangerl I, Bonetti EP, Pieri L, Richards JG (1990) In vitro and in vivo evaluation of iodine-123-Ro16-0154: a new imaging agent for SPECT investigations of benzodiazepine receptors. J Nucl Med 31:1007-1014
320. Francis BF, Rzeszotarski WJ, Eckelman WC, Reba RC (1982) Nucleophilic iodination of 3-quinuclidinyl benzilates. J Label Comp Radiopharm 19:1499-1500
321. Rzeszotarski WJ, Eckelman WC, Francis BE, Simms DA, Gibson RE, Jagoda EM, Grissom MP, Eng RR, Conklin JJ, Reba RC (1984) Synthesis and evaluation of radioiodinated derivatives of 1-azabicyclo[2.2.2]oct-3-yl-alpha-hydroxy-alpha- (4-iodophenyl)-alpha-phenylacetate as potential radiopharmaceuticals. J Med Chem 27:156-160
322. Frangin Y, Caillet M, Chalon S, Huguet F, Foulon C, Desplanches G, Baulieu JL, Besnard JC, Guilloteau D (1990) A new method to prepare no-carrier-added iodinated spirodecanone derivatives: application to dopaminergic and serotoninergic ligands. J Label Comp Radiopharm 28:1363-1373
323. 123I]iodo-lisuride. J Label Comp Radiopharm 30:377
324. 123I]Iodo-a-methyl- L-tyrosine: uptake mechanisms and clinical applications. Nucl Med Biol 29:625-631
325. Tisljar U, Kloster G, Ritzl F, Stöcklin G (1979) Accumulation of radioiodinated L-amethyltyrosine in pancreas of mice: concise communication. J Nucl Med 20:973-976
326. 123I]iodomethoxytyrosine: a simplified preparation and metabolite analysis. J Label Comp Radiopharm 37:158-160
327. Krummeich C, Holschbach M, Stöcklin G (1994) Direct n. c.a. electrophilic radioiodination of tyrosine analogues; their in vivo stability and brain-uptake in mice. Appl Radiat Isot 45:929-935
328. 123I] IBZM: a potential dopamine D-2 receptor imaging agent. J Label Comp Radiopharm 27:691-700
329. Angelberger P, Brücke T, Podreka I, Zbiral E (1991) Optimized preparation of I-123-IBZM and I-123-IBZP for clinical SPECT studies of D-2 and D-1 receptors. J Label Comp Radiopharm 30:368-370
330. Knapp FF Jr, Goodman MM, Callahan AP, Kirsch G (1986) Radioiodinated 15-(p-iodophenyl)-3, 3-dimethylpentadecanoic acid: a useful new agent to evaluate myocardial fatty acid uptake. J Nucl Med 27:521-531
331. 123I]epidepride from trialkylstannyl precursors in the presence of chloramine-T. Some cautionary observations. J Label Comp Radiopharm 42:774-776
332. 125I] epidepride: a dopamine D-2 receptor antagonist radioligand. J Label Comp Radiopharm 29:745-751
333. Neumeyer JL, Wang SY, Milius RA, Baldwin RM, Zea-Ponce Y, Hoffer PB, Sybirska E, Al-Tikriti M, Charney DS, Malison RT, Laruelle M, Innis RB (1991) [I-123]-2-beta-carbomethoxy-3-beta-(4-iodophenyl) tropane: high-affinity SPECT radiotracer of monoamine reuptake sites in brain. J Med Chem 34:3144-3146
334. 123I]beta-CIT. Binding kinetics in the human brain. J Neural Transm Gen Sect 94:137-146
335. 123I-labelled 2-beta-carbomethoxy-3-beta-(4-iodophenyl) tropane in human brain. Eur J Nucl Med 20:783-786
336. Innis RB, Seibyl JP, Scanley BE, Laruelle M, Abi-Dargham A, Wallace E, Baldwin RM, Zea-Ponce Y, Zoghbi S, Wang S, Gao Y, Neumeyer JL, Charney DS, Hoffer PB, Marek KL (1993) Single-photon emission computed tomographic imaging demonstrates loss of striatal dopamine transporters in Parkinson's disease. Proc Natl Acad Sci USA 90:11965-11969
337. 123 124I]beta-CIT, plasma analysis and pharmacokinetic studies with SPECT and PET. Nucl Med Biol 22:977-984
338. Guilloteau D, Emond P, Baulieu JL, Garreau L, Frangin Y, Pourcelot L, Mauclaire L, Besnard JC, Chalon S (1998) Exploration of the dopamine transporter: in vitro and in vivo characterization of a high-affinity and high-specificity iodinated tropane derivative (E)-N-(3-iodoprop-2-enyl)-2beta- carbomethoxy-3beta-(40-methyl-phenyl) - nortropane (PE2I). Nucl Med Biol 25:331-337
339. Wilbur DS, Hadley SW, Hylarides MD, Abrams PG, Beaumier PA, Morgan AC, Reno JM, Fritzberg AR (1989) Development of a stable radioiodinating reagent to label monoclonal antibodies for radiotherapy of cancer. J Nucl Med 30:216-226
340. 123I]iomazenil by iododestannylation: implications for the reaction mechanism. Appl Radiat Isot 45:63-68
341. 125I-labelled iodobenzodiazepines. Appl Radiat Isot 42:173-175
342. 123I]iodobenzylguanidine: synthesis and preliminary evaluation. Nucl Med Biol 22:61-64
343. 131I]]iodobenzylguanidine. Appl Radiat Isot 44:621-628